A Wild Week Hints At What Comes Next The recent correction and all the volatility over the past month are setting the stage for the last phase of the current AI bull market.
Country ETFs Since Liberation Day And Pause Day The average country ETF is down 4% since 4/2, so SPY has underperformed that since Trump's Rose Garden announcement.
From Rally To Rollover: It’s Whiplash Week In The Markets The markets closed up today, nearly 2%, which would be nice if this were anything like a normal market.
Friday's after hours session: top gainers and losers As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Bulls, Bears, And Icebergs - Oh My, What A Week Maybe, just maybe, it’s time to stop throwing our critical market-stabilizing toys out of the pram.
S&P 500 Earnings Dashboard 25Q1 - Friday, April 11 25Q1 Y/Y earnings are expected to be 8.0%. Excluding the energy sector, the Y/Y earnings estimate is 9.6%.
Microsoft Stock Is A Winner In This Market Turmoil And Looks Cheap Here Microsoft Corp stock has held up much better than its technology peers in the latest stock market volatility.
The Fog Of Tariffs What was supposed to be just reciprocal duties placed on some nations became across-the-board taxes that were much higher.
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.
